세계의 류코트리엔 조절제 시장 보고서(2025년)

Leukotriene Modifiers Global Market Report 2025

US $ 4,490 ￦ 6,301,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,108,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,914,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

류코트리엔 조절제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 CAGR 6.2%로 302억 달러에 달할 것으로 예상됩니다. 이 예측 기간의 성장은 의료 인프라 증가와 가처분 소득 증가로 인한 신흥국 시장의 큰 성장 기회, 맞춤형 의료로의 전환, 원격의료 및 원격 환자 모니터링의 채택 증가, 신약 후보물질 및 제형에 초점을 맞춘 연구 개발의 지속, 규제 프레임워크의 변화 예측 등에 기인합니다. 예측 기간의 주요 동향으로는 모바일 앱, 웨어러블 기기 등 디지털 헬스 기술 통합, 인공지능(AI) 및 머신러닝 알고리즘의 통합, 새로운 치료 타깃 발굴, 환자 참여형 솔루션 및 도구 개발, 의약품 제조의 효율성과 유연성을 높이기 위한 연속 의약품 제조의 효율성과 유연성을 높이기 위한 연속 제조 공정의 채택 등이 있습니다.

천식 및 알레르기 질환의 유병률 증가는 향후 류코트리엔 변성제 시장의 성장을 촉진할 것으로 예상됩니다. 천식 및 알레르기 질환은 다양한 알레르겐에 의해 유발되는 다양한 면역계 과민성 장애를 포함하며, 염증 및 관련 증상을 유발합니다. 천식 및 알레르기 질환의 증가는 오염 물질에 대한 노출 증가, 기후 패턴의 변화, 기온 상승, 인구 밀도 증가 등의 요인에 기인합니다. 류코트리엔 조절제는 천식 및 알레르기 증상을 관리하고 완화하는 데 중요한 역할을 합니다. 또한, 호흡 기능을 개선하고 염증을 억제하며 만성 호흡기질환을 앓고 있는 사람들에게 보다 안전하고 효과적인 치료법을 제공합니다. 예를 들어, 미국 국립보건통계센터(NCHS)가 2024년 5월에 발표한 자료에 따르면, 미국 18세 이상 성인의 천식 유병률은 2021년 8.4%에서 2022년 8.7%로 증가할 것으로 예상됩니다. 또한 같은 연령대 성인의 지난 12개월 내 천식 에피소드 발생률은 2021년 3.3%에서 2022년 3.7%로 상승했습니다. 따라서 천식 및 알레르기 질환의 발생률 증가는 류코트리엔 변성제 시장의 주요 촉진요인입니다.

류코트리엔 조절제 시장의 주요 업체들은 보다 편리하고 효율적인 치료에 대한 수요 증가에 대응하기 위해 제품 라인업을 확장하고 서방형(ER) 정제를 포함한 제네릭 제제 개발에 주력하고 있습니다. 서방형(ER) 제네릭 정제는 유효성분이 장기간에 걸쳐 서서히 방출되도록 설계되어 즉시 방출형 제제에 비해 투여 일정과 편의성이 개선되었습니다. 예를 들어, Camber Pharmaceuticals Inc.는 2023년 4월 Zileuton ER 정제를 포트폴리오에 추가했습니다. 이 정제는 성인과 12세 이상의 소아 및 청소년의 천식 예방 및 만성 치료에 적응증을 가지고 있습니다. 급성 천식 발작의 회복을 목적으로 하지는 않지만, 천식 악화 시 지속적으로 투여할 수 있습니다. 질레톤ER정은 600mg 용량으로 120정씩 포장되어 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 류코트리엔 조절제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 류코트리엔 조절제 시장 : 성장률 분석
• 세계의 류코트리엔 조절제 시장 실적 : 규모와 성장, 2019-2024
• 세계의 류코트리엔 조절제 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 류코트리엔 조절제 전체 시장(TAM)

제6장 시장 세분화

• 세계의 류코트리엔 조절제 시장 : 약제 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Montelukast
• Zafirlukast
• Zileuton ER
• Zileuton
• 세계의 류코트리엔 조절제 시장 : 형태별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 태블릿
• 츄어블정
• 경구 과립
• 세계의 류코트리엔 조절제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 드럭스토어
• 온라인 약국
• 세계의 류코트리엔 조절제 시장, Montelukast 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정제 처방
• 츄어블정 제제
• 경구 과립
• 세계의 류코트리엔 조절제 시장, Zafirlukast 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정제 처방
• 세계의 류코트리엔 조절제 시장, Zileuton ER 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 서방형 정제 제제
• 세계의 류코트리엔 조절제 시장, Zileuton 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정제 처방
• 경구 현탁액 제제

제7장 지역별·국가별 분석

• 세계의 류코트리엔 조절제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 류코트리엔 조절제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 류코트리엔 조절제 시장 : 경쟁 구도
• 류코트리엔 조절제 시장 : 기업 개요
  • Merck And Co. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Hetero Drugs Limited
• Sun Pharmaceutical Industries
• Sumitomo Dainippon Pharma
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories
• Apotex Pharmaceutical Holdings Inc.
• Torrent Pharmaceuticals Ltd.
• DAVA Pharmaceuticals
• Alembic Pharmaceuticals Ltd.
• Starallergens Greer Ltd

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 류코트리엔 조절제 시장 2029 : 새로운 기회를 제공하는 국가
• 류코트리엔 조절제 시장 2029 : 새로운 기회를 제공하는 부문
• 류코트리엔 조절제 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Leukotriene modifiers are a class of medications used to manage and treat allergic rhinitis (hay fever) and asthma by blocking the action or production of leukotrienes in the body. Leukotrienes are chemicals that contribute to inflammation, bronchoconstriction (narrowing of the airways), and mucus production associated with these conditions. By inhibiting leukotrienes, these medications help reduce symptoms such as wheezing, shortness of breath, and nasal congestion.

The main types of leukotriene modifiers include montelukast, zafirlukast, zileuton er, and zileuton. Montelukast, for instance, is a leukotriene receptor antagonist used to prevent and manage asthma and relieve symptoms of seasonal allergies. These medications are available in various forms such as tablets, chewable tablets, and oral granules, and are distributed through channels such as hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

The leukotriene modifiers market research report is one of a series of new reports from the business research company that provides leukotriene modifiers market statistics, including leukotriene modifiers industry global market size, regional shares, competitors with an leukotriene modifiers market share, detailed leukotriene modifiers market segments, market trends and opportunities, and any further data you may need to thrive in the leukotriene modifiers industry. This leukotriene modifiers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukotriene modifiers market size has grown strongly in recent years. It will grow from $22.33 billion in 2024 to $23.77 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to the growing impact of regulatory approvals, rising awareness among healthcare professionals and patients about the benefits of leukotriene modifiers, expiration of patents for certain leukotriene modifier drugs allowed for the entry of generic versions, expansion of indications for leukotriene modifiers, growing collaborations between pharmaceutical companies and healthcare organizations.

The leukotriene modifiers market size is expected to see strong growth in the next few years. It will grow to $30.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to significant growth opportunities in emerging markets due to increasing healthcare infrastructure and rising disposable incomes shift towards personalized medicine, increasing adoption of telemedicine and remote patient monitoring, ongoing research and development efforts focused on novel drug candidates and formulations, and anticipated changes in regulatory frameworks. Major trends in the forecast period include the integration of digital health technologies such as mobile apps and wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, exploration of novel therapeutic targets, development of patient engagement solutions and tools, and adoption of continuous manufacturing processes for increased efficiency and flexibility in drug production.

The increasing prevalence of asthma and allergic conditions is poised to drive the growth of the leukotriene modifier market in the future. Asthma and allergic conditions encompass a range of immune system hypersensitivity disorders triggered by various allergens, leading to inflammation and related symptoms. The rise in asthma and allergic conditions can be attributed to factors such as heightened exposure to pollutants, changing climate patterns, rising temperatures, and increased population density. Leukotriene modifiers play a crucial role in managing and alleviating symptoms associated with asthma and allergic conditions. They also improve respiratory function, reduce inflammation, and offer a safer and more effective treatment option for individuals with chronic respiratory issues. For example, data published by the National Center for Health Statistics (NCHS) in May 2024 indicated an increase in the prevalence of current asthma among adults aged 18 and over in the United States, from 8.4% in 2021 to 8.7% in 2022. Additionally, the incidence of asthma episodes within the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, the rising incidence of asthma and allergic conditions is a key driver for the leukotriene modifier market.

Major companies in the leukotriene modifier market are concentrating on developing generic formulations, including extended-release (ER) tablets, to broaden their product offerings and meet the growing demand for more convenient and efficient treatments. Generic extended-release (ER) tablets are designed to gradually release active ingredients over an extended period, offering improved dosing schedules and convenience compared to immediate-release formulations. For instance, Camber Pharmaceuticals Inc. added Zileuton ER Tablets to its portfolio in April 2023. These tablets are indicated for asthma prophylaxis and chronic treatment in adults and children aged 12 years and older. They are not meant for acute asthma attack reversal but can be continued during such exacerbations. Zileuton ER Tablets are available in 600 mg strength in 120-count bottles.

In April 2023, SK Capital Partners LP acquired Apotex Pharmaceutical Holdings Inc. to leverage its renowned brand, diverse product portfolio, global presence, and skilled team for growth and shareholder value enhancement. Apotex Pharmaceutical Holdings Inc., based in Canada, manufactures leukotriene modifiers such as Montelukast drugs.

Major companies operating in the leukotriene modifiers market are Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.

North America was the largest region in the leukotriene modifiers market in 2024. The regions covered in the leukotriene modifiers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukotriene modifiers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukotriene modifiers market consists of sales of modafinil, armodafinil, amphetamine-based stimulants, fluoxetine, and sertraline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukotriene Modifiers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukotriene modifiers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukotriene modifiers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukotriene modifiers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Montelukast; Zafirlukast; Zileuton ER; Zileuton
• 2) By Form: Tablets; Chewable Tablets; Oral Granules
• 3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies
• Subsegments:
• 1) By Montelukast: Tablet Formulation; Chewable Tablet Formulation; Oral Granules
• 2) By Zafirlukast: Tablet Formulation
• 3) By Zileuton ER: Extended-Release Tablet Formulation
• 4) By Zileuton: Tablet Formulation; Oral Suspension Formulation
• Companies Mentioned: Merck And Co.; Sanofi SA; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukotriene Modifiers Market Characteristics

3. Leukotriene Modifiers Market Trends And Strategies

4. Leukotriene Modifiers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Leukotriene Modifiers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Leukotriene Modifiers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Leukotriene Modifiers Market Growth Rate Analysis
• 5.4. Global Leukotriene Modifiers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Leukotriene Modifiers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Leukotriene Modifiers Total Addressable Market (TAM)

6. Leukotriene Modifiers Market Segmentation

• 6.1. Global Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Montelukast
• Zafirlukast
• Zileuton ER
• Zileuton
• 6.2. Global Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Chewable Tablets
• Oral Granules
• 6.3. Global Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• 6.4. Global Leukotriene Modifiers Market, Sub-Segmentation Of Montelukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• Chewable Tablet Formulation
• Oral Granules
• 6.5. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zafirlukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• 6.6. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton ER, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release Tablet Formulation
• 6.7. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• Oral Suspension Formulation

7. Leukotriene Modifiers Market Regional And Country Analysis

• 7.1. Global Leukotriene Modifiers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Leukotriene Modifiers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukotriene Modifiers Market

• 8.1. Asia-Pacific Leukotriene Modifiers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukotriene Modifiers Market

• 9.1. China Leukotriene Modifiers Market Overview
• 9.2. China Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukotriene Modifiers Market

• 10.1. India Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukotriene Modifiers Market

• 11.1. Japan Leukotriene Modifiers Market Overview
• 11.2. Japan Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukotriene Modifiers Market

• 12.1. Australia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukotriene Modifiers Market

• 13.1. Indonesia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukotriene Modifiers Market

• 14.1. South Korea Leukotriene Modifiers Market Overview
• 14.2. South Korea Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukotriene Modifiers Market

• 15.1. Western Europe Leukotriene Modifiers Market Overview
• 15.2. Western Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukotriene Modifiers Market

• 16.1. UK Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukotriene Modifiers Market

• 17.1. Germany Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukotriene Modifiers Market

• 18.1. France Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukotriene Modifiers Market

• 19.1. Italy Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukotriene Modifiers Market

• 20.1. Spain Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukotriene Modifiers Market

• 21.1. Eastern Europe Leukotriene Modifiers Market Overview
• 21.2. Eastern Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukotriene Modifiers Market

• 22.1. Russia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukotriene Modifiers Market

• 23.1. North America Leukotriene Modifiers Market Overview
• 23.2. North America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukotriene Modifiers Market

• 24.1. USA Leukotriene Modifiers Market Overview
• 24.2. USA Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukotriene Modifiers Market

• 25.1. Canada Leukotriene Modifiers Market Overview
• 25.2. Canada Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukotriene Modifiers Market

• 26.1. South America Leukotriene Modifiers Market Overview
• 26.2. South America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukotriene Modifiers Market

• 27.1. Brazil Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukotriene Modifiers Market

• 28.1. Middle East Leukotriene Modifiers Market Overview
• 28.2. Middle East Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukotriene Modifiers Market

• 29.1. Africa Leukotriene Modifiers Market Overview
• 29.2. Africa Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukotriene Modifiers Market Competitive Landscape And Company Profiles

• 30.1. Leukotriene Modifiers Market Competitive Landscape
• 30.2. Leukotriene Modifiers Market Company Profiles
  • 30.2.1. Merck And Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Leukotriene Modifiers Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim International GmbH
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Hetero Drugs Limited
• 31.5. Sun Pharmaceutical Industries
• 31.6. Sumitomo Dainippon Pharma
• 31.7. Chiesi Farmaceutici S.p.A.
• 31.8. Cipla Limited
• 31.9. Aurobindo Pharma Limited
• 31.10. Dr. Reddy's Laboratories
• 31.11. Apotex Pharmaceutical Holdings Inc.
• 31.12. Torrent Pharmaceuticals Ltd.
• 31.13. DAVA Pharmaceuticals
• 31.14. Alembic Pharmaceuticals Ltd.
• 31.15. Starallergens Greer Ltd

32. Global Leukotriene Modifiers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukotriene Modifiers Market

34. Recent Developments In The Leukotriene Modifiers Market

35. Leukotriene Modifiers Market High Potential Countries, Segments and Strategies

• 35.1 Leukotriene Modifiers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Leukotriene Modifiers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Leukotriene Modifiers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료